Phenylalanine Derivatives Read more about Phenylalanine Derivatives US Patent 7,825,216Filed on 2007-05-16
METHODS AND COMPOSITIONS FOR THE EX VIVO HIGH-THROUGHPUT DETECTION OF PROTEIN/PROTEIN INTERACTIONS Read more about METHODS AND COMPOSITIONS FOR THE EX VIVO HIGH-THROUGHPUT DETECTION OF PROTEIN/PROTEIN INTERACTIONS European Patent05852125.3Filed on 2005-11-22
Combining Phage Lambda Genetics And Protein Display For The Identification Of Multi Complex Protein Structures. Read more about Combining Phage Lambda Genetics And Protein Display For The Identification Of Multi Complex Protein Structures. US Application 11/719,925Filed on 2007-05-22
Antigens, Means And Method For The Diagnosis Of Lymphadenopathy And Acquired Immune Deficiency Syndrome Read more about Antigens, Means And Method For The Diagnosis Of Lymphadenopathy And Acquired Immune Deficiency Syndrome Canada617167Filed on 1985-09-19
Cloned DNA Sequences, Hybridizable with Genomic RNA of Lymphadenopathy-Associated Virus (LAV) Read more about Cloned DNA Sequences, Hybridizable with Genomic RNA of Lymphadenopathy-Associated Virus (LAV) Canada491128Filed on 1985-09-19
ANTIGENS, MEANS AND METHOD FOR THE DIAGNOSIS OF LYMPHADENOPATHY AND ACQUIRED IMMUNE DEFICIENCY SYNDROME Read more about ANTIGENS, MEANS AND METHOD FOR THE DIAGNOSIS OF LYMPHADENOPATHY AND ACQUIRED IMMUNE DEFICIENCY SYNDROME Canada443605Filed on 1983-12-19
Envelope Antigens of HIV-1 Read more about Envelope Antigens of HIV-1 Canada493,377Filed on 1985-10-18
Methods and Compositions for Stimulating and Inhibiting TGF-B Activity Read more about Methods and Compositions for Stimulating and Inhibiting TGF-B Activity Canada2590837Filed on 1994-08-12
MANGANESE SUPEROXIDE DISMUTASE VAL16ALA POLYMORPHISM PREDICTS RESISTANCE TO DOXORUBICIN CANCER THERAPY Read more about MANGANESE SUPEROXIDE DISMUTASE VAL16ALA POLYMORPHISM PREDICTS RESISTANCE TO DOXORUBICIN CANCER THERAPY Patent Cooperation TreatyPCT/US2007/068588Filed on 2007-05-09
Transforming Growth Factor Beta(TGF-BETA) Antagonist Selectively Neutralize PATHOLOGICAL TGF BETA. Read more about Transforming Growth Factor Beta(TGF-BETA) Antagonist Selectively Neutralize PATHOLOGICAL TGF BETA. US Application 11/760,638Filed on 2007-06-08